BCM
Burrage Capital Management Portfolio holdings
AUM
$99.7M
1-Year Return
65.92%
This Quarter Return
+51.19%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$143M
AUM Growth
+$41.3M
(+41%)
Cap. Flow
+$2.17M
Cap. Flow
% of AUM
1.52%
Top 10 Holdings %
Top 10 Hldgs %
59.86%
Holding
34
New
3
Increased
4
Reduced
11
Closed
8
Top Buys
| 1 |
ADC Therapeutics
ADCT
|
$6.32M |
| 2 |
Fulcrum Therapeutics
FULC
|
$5.33M |
| 3 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$3.68M |
| 4 |
Insmed
INSM
|
$2.75M |
| 5 |
Merus
MRUS
|
$2.26M |
Top Sells
| 1 |
CytomX Therapeutics
CTMX
|
$3.46M |
| 2 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$3.29M |
| 3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$2.78M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$2.11M |
| 5 |
Y-mAbs Therapeutics
YMAB
|
$2.11M |
Sector Composition
| 1 | Healthcare | 96.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
26
Autolus Therapeutics
AUTL
$389M
| $241K | 0.17% |
15,006
| – | – |
|
|
27
CytomX Therapeutics
CTMX
$376M
| – | – |
-482,982
| Closed | -$3.46M |
|
28
Ironwood Pharmaceuticals
IRWD
$188M
| – | – |
-115,899
| Closed | -$1.17M |
|
29
Wave Life Sciences
WVE
$1.32B
| – | – |
-56,699
| Closed | -$556K |
|
|
30
Xenon Pharmaceuticals
XENE
$3.02B
| – | – |
-200,000
| Closed | -$2.11M |
|
|
TVRD
31
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| – | – |
-7,188
| Closed | -$3.29M |
|
|
VIRX
32
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-19,502
| Closed | -$280K |
|
|
TCDA
33
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – |
-131,661
| Closed | -$2.78M |
|
|
AERI
34
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-88,445
| Closed | -$1.19M |
|